STING Signaling in Cancer Cells: Important or Not?
Archivum Immunologiae et Therapiae Experimentalis · 2018-04 · 66 (2) · 125-132
DOI: 10.1007/s00005-017-0481-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, online erschienen am 26.07.2017. Verfasst von Olga Sokolowska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097, Warsaw, Poland. omusielak@uw.edu.pl. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Stimulator of interferon genes (STING) is an adaptor protein that plays an important role in the activation of type I interferons in response to cytosolic nucleic acid ligands. Recent evidence indicates involvement of the STING pathway in the induction of antitumor immune response. Therefore, STING agonists are now being extensively developed as a new class of cancer therapeutics. However, little is known about the consequences of activated STING-mediated signaling in cancer cells on the efficacy of the antitumor treatment. It has been shown that activation of the STING-dependent pathway in cancer cells can result in tumor infiltration with immune cells and modulation of the anticancer immune response. Understanding the function of STING pathway in cancer cells might provide important insights into the development of effective therapeutic strategies. This review focuses on the role of STING pathway in cancer cells, the largely unknown topic that has recently emerged to be important in the context of STING-mediated antitumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097, Warsaw, Poland. omusielak@uw.edu.pl.
- Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, Warsaw, Poland. omusielak@uw.edu.pl.
- Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland. omusielak@uw.edu.pl.
- Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097, Warsaw, Poland.
- Genomic Medicine, Medical University of Warsaw, Warsaw, Poland.
- Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Sokolowska, O., & Nowis, D. (2018). STING Signaling in Cancer Cells: Important or Not?. Archivum Immunologiae et Therapiae Experimentalis, 66(2), 125-132. https://doi.org/10.1007/s00005-017-0481-7
Vancouver
Sokolowska O, Nowis D. STING Signaling in Cancer Cells: Important or Not?. Archivum Immunologiae et Therapiae Experimentalis. 2018;66(2):125-132. doi:10.1007/s00005-017-0481-7
BibTeX
@article{Sokolowska2018,
author = {Sokolowska, Olga and Nowis, Dominika},
title = {STING Signaling in Cancer Cells: Important or Not?},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2018},
volume = {66},
number = {2},
pages = {125--132},
doi = {10.1007/s00005-017-0481-7}
}
EUVIMED